Latest hormone therapy Stories
Nationwide poll found 7 out of 10 women suffering from menopausal symptoms are not treated
A study in this week's PLoS Medicine suggests that increasing height and, among women who have never taken menopausal hormone therapy, increased body mass index are risk factors for developing ovarian cancer.
In the past decade, results from large prospective cohort studies and the Women's Health Initiative (WHI) randomized placebo-controlled hormone therapy trials have substantially changed thoughts about how estrogen alone and estrogen plus progestin influence the risk of breast cancer.
A first-of-its kind study led by Xiao-Cheng Wu, MD, MPH, Associate Professor of Public Health at LSU Health Sciences Center New Orleans, reports that a significant number of women are not receiving guideline-recommended treatment for breast cancer and what factors contribute.
Men with locally advanced or high-risk prostate cancer who receive radiation and hormone therapy live longer and are less likely to die from their disease, according to this study.
- The word or words serving to define another word or expression, as in a dictionary entry.